Breast Biopsy Market Trends

  • Report ID: 747
  • Published Date: Nov 07, 2024
  • Report Format: PDF, PPT

Breast Biopsy Market Trends

Growth Driver

  • Increasing Consumption of Unhealthy Foods- Breast cancer is increasing globally due to the increasing consumption of unhealthy and fried foods by women worldwide. One study found that women who regularly ate fried food were 4.5 times more likely to develop breast cancer than other women her age, with a very significant association between highly fried foods and the risk of breast cancer.
  • Technological Advances in Breast Biopsy Equipment: Technological advances in breast biopsy devices have led to the development of more precise and less invasive procedures. For example, 3D mammography is becoming increasingly popular because it provides higher-resolution images that can detect smaller lesions. One study found that 3D mammography was associated with a 41% increased chance of detecting invasive breast cancer compared with traditional 2D mammography.
  • Raise Awareness About Breast Cancer Screening: Growing awareness of the importance of early detection and diagnosis of breast cancer, through breast cancer screening, leading to an increase in the number of women undergoing breast biopsy procedures. According to a survey, nearly 75% of women aged 40 and over said they had a mammogram in the past two years. 
  • Increased Spending on Health: Increasing healthcare costs worldwide are driving the growth of the global breast biopsy market. According to a study, global health expenditure was valued at USD 7.1 trillion in 2019 and is expected to reach USD 12.8 trillion by 2026. As healthcare costs continue to rise, more resources will be allocated to breast cancer screening and diagnosis, which will lead to an increase in demand for breast biopsy procedures. 

Challenges

  • High Cost of Breast Biopsy Procedures – Breast biopsy procedures can be expensive, particularly in countries where healthcare costs are high. This can make it difficult for some patients to access the procedure, leading to delays in diagnosis and treatments.
  • Lack of Awareness and Education
  • Fear and Discomfort

Breast Biopsy Market: Key Insights

The global breast biopsy device market is observing vibrant growth on the back of increasing demand of diagnostic procedures for scaling, or crusting of the breast skin. Advancements in healthcare industry in the past few years and growing breast cancer incidences is projected to drive breast biopsy device market besides the wide range of functions of breast biopsy device in detection of abnormal changes in the nipple for instance, cellulite and congealing during the forecast period.

Breast biopsy device market is anticipated to record a CAGR of 5.5% over the forecast period. The Breast biopsy devices market is expected to value at USD 14.3 million at the end of the forecast period. Many multi-national companies are concentrating towards new product advances in breast biopsy devices. Moreover, rising cases of breast cancers reported by European Breast Cancer Coalition, International Association of Cancer Registries and others, is subsequently estimated to drive the breast biopsy market rapidly. On the basis of regional platform, global Breast Biopsy Device market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

Being a developed region with excellent healthcare facilities, North America is panned to observe significant growth in breast biopsy device market due to rising breast biopsy device usage for detecting cellulite and surgical cysts in women. North America is estimated to be followed by Asia Pacific in terms of usage due to expanding breast biopsy device requirements in growing female cancer population across the region. Europe is expected to drive demand and positively impact breast biopsy device market growth over the forecast period owing to increasing geriatric female population suffering from breast cancer across the region.

CLICK TO DOWNLOAD FREE SAMPLE  

Breast biopsy device market Graph

Base Year

2024

Forecast Year

2025-2037

CAGR

6.5%

Base Year Market Size (2024)

USD 3.4 billion

Forecast Year Market Size (2037)

USD 7.71 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 747
  • Published Date: Nov 07, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of breast biopsy is estimated at USD 3.58 billion.

The breast biopsy market size was valued at USD 3.4 billion in 2024 and is set to exceed USD 7.71 billion by 2037, registering over 6.5% CAGR during the forecast period i.e., between 2025-2037. The growing incidence of breast cancer and the expansion of healthcare spending will drive the market growth.

Asia Pacific industry is expected to account for largest revenue share of 35% by 2037, impelled by increase in the percentage of the aging population in the region.

The major players in the market include Hologic, Inc., Danaher CorporationBD (Becton, Dickinson, and Company)Cook Medical LLCArgon Medical Devices, Inc.B. Braun Melsungen AGC.R. Bard, Inc.Devicor Medical Products, Inc.Cardinal Health, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample